Chargement en cours...
Bevacizumab in the treatment of acute central/hemicentral retinal vein occlusions
Even if bevacizumab is unlicensed, a majority of retina specialists still currently recommends it in retinal vein occlusion-related macular edema. For the first time, the results of our studies showed evidence suggesting that an early treatment administered immediately after the onset of venous occl...
Enregistré dans:
| Publié dans: | Rom J Ophthalmol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Romanian Society of Ophthalmology
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5720126/ https://ncbi.nlm.nih.gov/pubmed/29450339 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|